{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:06Z","timestamp":1790803266300,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00347-020-01279-z","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T14:38:31Z","timestamp":1607524711000},"page":"68-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Erfolgreiche Behandlung der okul\u00e4ren Rosazea im Kindesalter mit 1,5\u202f% Azithromycin-Augentropfen","Pediatric ocular rosacea effectively treated with topical 1.5% azithromycin eye drops"],"prefix":"10.1007","volume":"118","author":[{"given":"Daniela A.","family":"Starosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"1279_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/ICU.0000000000000399","volume":"28","author":"ST Rousta","year":"2017","unstructured":"Rousta\u00a0ST (2017) Pediatric blepharokeratoconjunctivitis: Is there a\u00a0\u201cright\u201d treatment? Curr Opin Ophthalmol 28:449\u2013453","journal-title":"Curr Opin Ophthalmol"},{"key":"1279_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0002-9394(03)00890-0","volume":"137","author":"SA Nazir","year":"2004","unstructured":"Nazir\u00a0SA, Murphy\u00a0S, Siatkowski\u00a0RM et\u00a0al (2004) Ocular rosacea in childhood. Am J Ophthalmol 137:138\u2013144","journal-title":"Am J Ophthalmol"},{"key":"1279_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/ICO.0b013e31802e3a54","volume":"26","author":"KE Donaldson","year":"2007","unstructured":"Donaldson\u00a0KE, Karp\u00a0CL, Dunbar\u00a0MT (2007) Evaluation and treatment of children with ocular rosacea. Cornea 26:42\u201346","journal-title":"Cornea"},{"key":"1279_CR4","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/jdv.14402","volume":"31","author":"LI Gonser","year":"2017","unstructured":"Gonser\u00a0LI, Gonser\u00a0CE, Deuter\u00a0C et\u00a0al (2017) Systemic therapy of ocular and cutaneous rosacea in children. J\u00a0Eur Acad Dermatol Venereol 31:1732\u20131738","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1279_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1869-5760-3-38","volume":"3","author":"S Doan","year":"2013","unstructured":"Doan\u00a0S, Gabison\u00a0E, Chiambaretta\u00a0F et\u00a0al (2013) Efficacy of azithromycin 1.5\u202f% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis. J\u00a0Ophthalmic Inflamm Infect 3:1\u20136","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1279_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1067\/mpa.2000.110339","volume":"4","author":"DM Meisler","year":"2000","unstructured":"Meisler\u00a0DM, Raizman\u00a0MB, Traboulsi\u00a0EI (2000) Oral erythromycin treatment for childhood blepharokeratitis. J\u00a0AAPOS 4:379\u2013380","journal-title":"J AAPOS"},{"key":"1279_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jaapos.2009.11.021","volume":"14","author":"IBY Wong","year":"2010","unstructured":"Wong\u00a0IBY, Nischal\u00a0KK (2010) Managing a\u00a0child with an external ocular disease. J\u00a0AAPOS 14:68\u201377","journal-title":"J AAPOS"},{"key":"1279_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ana.410280417","volume":"28","author":"EF May","year":"1990","unstructured":"May\u00a0EF, Calvert\u00a0PC (1990) Aggravation of myasthenia gravis by erythromycin. Ann Neurol 28:577\u2013579","journal-title":"Ann Neurol"},{"key":"1279_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/bjophthalmol-2011-300771","volume":"96","author":"S Hamada","year":"2012","unstructured":"Hamada\u00a0S, Khan\u00a0I, Denniston\u00a0AK et\u00a0al (2012) Childhood blepharokeratoconjunctivitis: characterising a\u00a0severe phenotype in white adolescents. Br J Ophthalmol 96:949\u2013955","journal-title":"Br J Ophthalmol"},{"key":"1279_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ajo.2006.06.047","volume":"142","author":"A \u00c7etinkaya","year":"2006","unstructured":"\u00c7etinkaya\u00a0A, Akova\u00a0YA (2006) Pediatric ocular acne Rosacea: long-term treatment with systemic antibiotics. Am J Ophthalmol 142:816. https:\/\/doi.org\/10.1016\/j.ajo.2006.06.047","journal-title":"Am J Ophthalmol"},{"key":"1279_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4103\/0028-3886.53270","volume":"57","author":"S Pradhan","year":"2009","unstructured":"Pradhan\u00a0S, Pardasani\u00a0V, Ramteke\u00a0K (2009) Azithromycin-induced myasthenic crisis: Reversibility with calcium gluconate. Neurol India 57:352","journal-title":"Neurol India"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01279-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-020-01279-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01279-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T16:40:37Z","timestamp":1610642437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-020-01279-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01279-z","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"assertion":[{"value":"9 December 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.A.\u00a0Starosta und B.\u00a0Lorenz geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}